Viyash Scientific Withdraws India Ratings, Continues With ICRA Ratings
Viyash Scientific Limited has withdrawn its bank loan facility ratings from India Ratings and Research. The company's bank loan facilities, amounting to ₹350 million (35 crore), have been withdrawn. Viyash Scientific continues to maintain its ratings with ICRA Ratings.
The impact is considered low as the company continues to be rated by another reputable agency (ICRA) with a stable outlook, indicating no immediate concern for its financial standing.
The withdrawal of a credit rating by one agency, while continuing with another, does not inherently present a positive or negative financial outcome. It is a procedural change.
Viyash Scientific Limited (formerly Sequent Scientific Limited) has announced the withdrawal of its credit ratings for bank loan facilities by India Ratings and Research (Ind-Ra), as requested by the company. The withdrawal pertains to bank loan facilities amounting to ₹350 million (35 crore).
India Ratings had affirmed the ratings on Viyash Scientific Limited’s bank facilities at ‘IND AA-’/Stable/' IND A1+' and simultaneously withdrawn them. The press release from India Ratings & Research regarding this withdrawal can be accessed via a provided link.
Despite this withdrawal, the company continues to be rated by ICRA Ratings, which had previously upgraded the rating to [ICRA] AA - (Stable) in a letter dated April 22, 2026. The company will also make this information available on its website, www.viyash.com.
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.